Court Stands by the 2015 Risperdal Verdict Amount
Court Stands by the 2015 Risperdal Verdict Amount
Introduction
In early 2015, a Philadelphia jury had passed a verdict of $2.5 million in damages to be paid to a Risperdal plaintiff which was also the first verdict for the antipsychotic drug Risperdal's alleged side effect of abnormal breast growth in males, stating that the defendant failed to warn about the risks involved. Following this, the defendant, J&J's Janssen Pharmaceutical's, filed a motion seeking a new trial which was upheld by a judge in Philadelphia. Most of the Risperdal cases are pending in the Philadelphia Court of Common Pleas in Pennsylvania, where a small group of cases is being heard as a part of bellwether trial process. In a few cases, settlements have been reached. At least 13,800 Risperdal lawsuits are filed against J&J nationwide.
Comments
Latest News
Study Finds Toxic Metals in E-Cigs and U-Cigs Vapors
Categories: E-Cigarette: JUUL
As health concerns about e-cigarette use escalate, emerging research suggests that a newer class of vaping products—ultrasonic cigarettes or u-cigarettes—may pose even greater risks.
A study published in Environmental Health Perspectives in…
Appeals Court Upholds $611M Roundup Verdict
Categories: Roundup
A Missouri appeals court has upheld a massive Roundup verdict originally totaling $1.5 billion, but significantly reduced the final amount Bayer and its Monsanto unit must pay to $611 million.
The case involved three plaintiffs from New…
Valsartan “Wave 2” Bellwether Trial Schedule Set by Court
Categories: Valsartan
As the first Valsartan bellwether trial approaches in September 2025, the federal judge overseeing the multidistrict litigation (MDL) is preparing a second set of trials.
This move comes in anticipation of the possibility that parties may…